학술논문

CNOT4 enhances the efficacy of anti‐PD‐1 immunotherapy in a model of non‐small cell lung cancer.
Document Type
Article
Source
FEBS Open Bio; Dec2020, Vol. 10 Issue 12, p2631-2639, 9p
Subject
NON-small-cell lung carcinoma
IMMUNE checkpoint inhibitors
UBIQUITIN ligases
PROGRAMMED cell death 1 receptors
TUMOR necrosis factors
IMMUNOTHERAPY
Language
ISSN
22115463
Abstract
Copyright of FEBS Open Bio is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)